Aurobindo Pharma share price climbed 1% in the morning trade on the BSE on Monday, 24 August, even as the pharma company said the US FDA conducted a routine inspection of its wholly owned step-down subsidiary in the US from 17th to 21st August 2026, which concluded with four observations.
Aurobindo Pharma shares opened at ₹1,619.75 against their previous close of ₹1,619.95 and rose over 1% to an intraday high of ₹1,637.75.
(This is a developing story. Please check back for fresh updates.)
